Vinci Compass Investments Ltd. (VINP)
NASDAQ: VINP · Real-Time Price · USD
9.48
-0.16 (-1.66%)
Aug 1, 2025, 4:00 PM - Market closed
CTI BioPharma Income Statement
Financials in millions BRL. Fiscal year is January - December.
Millions BRL. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2019 - 2020 |
|---|---|---|---|---|---|---|---|
Period Ending | Mar '25 Mar 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2019 - 2020 |
| 726.41 | 600.78 | 454.42 | 408.1 | 465.46 | 339.89 | Upgrade | |
Revenue Growth (YoY) | 57.50% | 32.21% | 11.35% | -12.32% | 36.94% | 14.55% | Upgrade |
Gross Profit | 726.41 | 600.78 | 454.42 | 408.1 | 465.46 | 339.89 | Upgrade |
Selling, General & Admin | 465.32 | 366.35 | 220.75 | 204.5 | 200.46 | 103.63 | Upgrade |
Other Operating Expenses | 23.37 | 16.93 | 11.73 | 9.06 | 8.81 | 7.33 | Upgrade |
Operating Expenses | 525.76 | 411.98 | 252.26 | 229.35 | 223 | 124.25 | Upgrade |
Operating Income | 200.65 | 188.8 | 202.16 | 178.75 | 242.46 | 215.65 | Upgrade |
Interest Expense | -72.76 | -70.17 | -33.54 | -15.17 | -12.57 | -12.41 | Upgrade |
Earnings From Equity Investments | -3.7 | -1.5 | - | - | - | - | Upgrade |
Currency Exchange Gain (Loss) | -19.05 | -20.81 | -0.03 | -0.47 | -0.37 | 0.22 | Upgrade |
Other Non Operating Income (Expenses) | 15.74 | 21.21 | 6.31 | 0.56 | 0.34 | 0.31 | Upgrade |
EBT Excluding Unusual Items | 120.88 | 117.54 | 174.89 | 163.67 | 229.86 | 203.77 | Upgrade |
Gain (Loss) on Sale of Investments | 56.88 | 64.32 | 110.36 | 94.17 | 27.98 | 8.83 | Upgrade |
Other Unusual Items | -4.61 | -19.92 | -15.87 | 13.97 | - | - | Upgrade |
Pretax Income | 173.15 | 161.95 | 269.39 | 271.81 | 257.84 | 212.6 | Upgrade |
Income Tax Expense | 46.95 | 45.98 | 49.93 | 52.41 | 49.23 | 43.45 | Upgrade |
Earnings From Continuing Operations | 126.19 | 115.97 | 219.46 | 219.4 | 208.62 | 169.15 | Upgrade |
Minority Interest in Earnings | 2.38 | 2.23 | 1.15 | 0.02 | - | 1.05 | Upgrade |
Net Income | 128.58 | 118.2 | 220.61 | 219.42 | 208.62 | 170.2 | Upgrade |
Net Income to Common | 128.58 | 118.2 | 220.61 | 219.42 | 208.62 | 170.2 | Upgrade |
Net Income Growth | -45.06% | -46.42% | 0.54% | 5.18% | 22.57% | 12.44% | Upgrade |
Shares Outstanding (Basic) | 57 | 55 | 55 | 56 | 55 | 9 | Upgrade |
Shares Outstanding (Diluted) | 59 | 57 | 55 | 57 | 55 | 9 | Upgrade |
Shares Change (YoY) | 5.96% | 2.74% | -3.05% | 3.18% | 537.82% | -0.05% | Upgrade |
EPS (Basic) | 2.24 | 2.14 | 4.02 | 3.89 | 3.77 | 19.60 | Upgrade |
EPS (Diluted) | 2.18 | 2.08 | 3.85 | 3.84 | 3.77 | 19.60 | Upgrade |
EPS Growth | -46.59% | -45.97% | 0.26% | 1.95% | -80.78% | 12.49% | Upgrade |
Free Cash Flow | 141.17 | 190.45 | 92.51 | 111.42 | 285.6 | 193.31 | Upgrade |
Free Cash Flow Per Share | 2.40 | 3.35 | 1.67 | 1.95 | 5.16 | 22.26 | Upgrade |
Dividend Per Share | 4.028 | 4.020 | 3.542 | 3.753 | 3.677 | - | Upgrade |
Dividend Growth | 12.36% | 13.49% | -5.63% | 2.07% | - | - | Upgrade |
Gross Margin | 100.00% | 100.00% | 100.00% | 100.00% | 100.00% | 100.00% | Upgrade |
Operating Margin | 27.62% | 31.43% | 44.49% | 43.80% | 52.09% | 63.45% | Upgrade |
Profit Margin | 17.70% | 19.68% | 48.55% | 53.77% | 44.82% | 50.07% | Upgrade |
Free Cash Flow Margin | 19.43% | 31.70% | 20.36% | 27.30% | 61.36% | 56.87% | Upgrade |
EBITDA | 216.92 | 201.9 | 210.61 | 183.73 | 246.38 | 220.29 | Upgrade |
EBITDA Margin | 29.86% | 33.61% | 46.35% | 45.02% | 52.93% | 64.81% | Upgrade |
D&A For EBITDA | 16.27 | 13.09 | 8.46 | 4.99 | 3.92 | 4.64 | Upgrade |
EBIT | 200.65 | 188.8 | 202.16 | 178.75 | 242.46 | 215.65 | Upgrade |
EBIT Margin | 27.62% | 31.43% | 44.49% | 43.80% | 52.09% | 63.45% | Upgrade |
Effective Tax Rate | 27.12% | 28.39% | 18.53% | 19.28% | 19.09% | 20.44% | Upgrade |
Updated Feb 27, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.